AI Insight
A multinational research team led by Professor Nurhasni Hasan has published a review examining next-generation local drug delivery systems for treating oral squamous cell carcinoma (OSCC). The review focuses on how these emerging delivery systems could overcome current treatment barriers for this common oral and head-neck malignancy. OSCC represents a significant contributor to global cancer-related morbidity and mortality.
Why it matters
Improved drug delivery systems for OSCC could enhance treatment effectiveness while potentially reducing systemic side effects by targeting medications directly to affected oral tissues. This research could inform the development of more effective therapeutic approaches for one of the most prevalent cancers affecting the oral cavity and head-neck region.
Understand the Science
A new review by a team of researchers from Indonesia, Japan and China, led by Professor Nurhasni Hasan from the Faculty of Pharmacy at Hasanuddin University in Indonesia, examines how emerging local drug delivery systems could be designed to overcome barriers to treating oral squamous cell carcinoma (OSCC), which is one of the most common malignancies affecting the oral cavity and head and neck region and contributes significantly to the global burden of cancer-related morbidity and mortality.
Source: Rethinking oral cancer treatment: A review of next-generation drug delivery systems